Deficient Repair of Alkylation Damage of DNA in Alzheimer’s Disease and Amyotrophic Lateral Sclerosis Cells
The etiology of amyotrophic lateral sclerosis (ALS) is still unknown. There are many pieces of evidence linking ALS, Alzheimer’s disease and Parkinson’s disease. These include the occasional clinical association of the conditions in the same patient and the same family, the endemic foci of all three diseases, and the presence of changes of one disease in the central nervous system of some patients dying of another of these diseases. There are several indications that alterations in genetic material may exist in these diseases, including decrease in nuclear and nucleolar size[l], alteration in chromatin of neurons and decrease in transcriptionally active chromatin. A possible DNA repair defect was implicated when it was observed that lymphocytes, lymphoblasts and skin fibroblasts from several different neurodegenerative disorders, including Alzheimer’s disease and ALS were more sensitive to DNA alkylating agents[4,5]. It has also been reported that lymphocytes from Alzheimer’s disease patients have increased sensitivity to bleomycin, 4-nitroquinoline- 1-oxide and mitomycin C which produce various other forms of DNA damage. We have further investigated the hypothesis that a DNA repair defect occurs in both of these diseases and offer direct evidence of a DNA repair defect in skin fibroblasts from ALS and Alzheimer’s disease patients after exposure to an alkylating agent.
KeywordsAmyotrophic Lateral Sclerosis Skin Fibroblast Motor Neuron Disease Population Doubling Level Methyl Methane Sulfonate
Unable to display preview. Download preview PDF.
- 3.E. M. Sajdel-Sulkowski, J. F. Coughlin, D. M. Staton, and C. A. Marotta, In vitro protein synthesis by messenger RNA from Alzheimer’s disease brain in biological aspects of Alzheimer’s disease, in:: R. Katzman, (ed.), Cold Spring Harbor Press, pp. 193–200 (1983).Google Scholar
- 4.R. E. Tarone, R. Scudiero, A. Brumback, L. E. Polinsky, B. E. Nee, B. E. Clatterbuck, and J. H. Robbins, Statistical analysis of the hypersensitivity to N-methyl-N-nitro-N-nitrosoguandine (MNNG) in muscular dystrophy (MD) of neurodegeneration, J. Cell. Biochem, 209: 1054 (Suppl.7B) (1983).Google Scholar
- 5.C. Kidson, P. Chen, P. Imray, and E. Gipps, Nervous system disease associated with dominant cellular radiosensitivity, J. Cell. Biochem 209: 1055 (Suppl. 7B) (1983).Google Scholar
- 6.B. Hirsch, L. Heston, and J. Cerbenka, Detection of DNA repair defect in Alzheimer’s disease by autogenic methods, Am. J. Human Genet., 34: 43A (1982).Google Scholar
- 8.A. D. Mitchell, D. A. Casciano, M. L. Meltz, D. E. Robinson, R. H. A. San, G. M. Williams and E. S. Von Hal, Unscheduled DNA synthesis tests, Mutat. Res., (1983).Google Scholar
- 9.K. W. Kohn, DNA as a target in cancer chemotherapy: measurement of macro-molecular DNA damage produced in mammalian cells by anticancer agents and carcinogens, Methods in Cancer Res., 291–345 (1979).Google Scholar
- 10.J. Regan, and R. Setlow, Two forms of repair in the DNA of human cells damaged by chemical carcinogens and mutagens, Cancer Res., 34: 3318–3325 (1979).Google Scholar
- 11.D. L. Stout and F. F. Becker, Fluorometric quantitation of single- stranded DNA, Analyt. Biochem. 127: 302–307 (1983).Google Scholar
- 15.W. G. Bradley, and F. Krasin, DNA hypothesis of ALS, in: L. P. Rowland, (ed.), Human Motor Neuron Disease, Raven Press, New York, pp. 493–500 (1982).Google Scholar